Circulating Biomarkers for Diagnosis, Prognosis and Treatment Response Prediction in Cancer - Part B: Volume 399
暫譯: 癌症診斷、預後及治療反應預測的循環生物標記 - B部分：第399卷
Galluzzi, Lorenzo, Spada, Sheila
- 出版商: Academic Press
- 出版日期: 2026-02-20
- 售價: $8,090
- 貴賓價: 9.5 折 $7,685
- 語言: 英文
- 頁數: 202
- 裝訂: Hardcover - also called cloth, retail trade, or trade
- ISBN: 0443414130
- ISBN-13: 9780443414138
海外代購書籍(需單獨結帳)
商品描述
Circulating Biomarkers for Diagnosis, Prognosis and Treatment Response Prediction in Cancer Patients, Part B delves into the crucial role of circulating biomarkers in cancer diagnosis and treatment monitoring. Specific chapters in this new release include Liquid biopsy approaches to capture minimal residual disease and therapy response in patients with early stage cancers, Identification of circulating biomarkers for cancer therapy-related cardiovascular toxicity, Extracellular Vesicles as Dynamic Biomarkers: Monitoring Therapeutic Responses and Drug Resistance in Cancer, and more. This comprehensive work explores the various types of biomarkers, their significance in early cancer detection, prognostication, and evaluation of therapeutic responses. It covers cutting-edge research on circulating tumor cells, cell-free DNA, exosomes, and other biomarkers that can revolutionize cancer management. Additionally, it discusses the challenges, advancements, and future prospects of utilizing circulating biomarkers in personalized cancer care.
商品描述(中文翻譯)
《癌症患者的循環生物標記：診斷、預後及治療反應預測，第二部分》深入探討了循環生物標記在癌症診斷和治療監測中的關鍵角色。本書的新章節包括液體活檢方法以捕捉早期癌症患者的微小殘留病和治療反應、識別與癌症治療相關的心血管毒性循環生物標記、作為動態生物標記的細胞外囊泡：監測癌症的治療反應和藥物抗性等。
這部綜合性著作探討了各種生物標記的類型、它們在早期癌症檢測、預後評估和治療反應評估中的重要性。它涵蓋了關於循環腫瘤細胞、游離DNA、外泌體及其他可能徹底改變癌症管理的生物標記的前沿研究。此外，還討論了在個性化癌症護理中利用循環生物標記的挑戰、進展和未來前景。
